You have 9 free searches left this month | for more free features.

Hepatitis B Infection

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hepatitis B, Osteoporosis, Osteoporosis Risk Trial (Patient Participation Form)

Not yet recruiting
  • Hepatitis B
  • +2 more
  • Patient Participation Form
  • (no location specified)
Mar 3, 2023

Hepatitis B, Chronic Trial in Auckland (VIR-3434, VIR-2218, TDF)

Recruiting
  • Hepatitis B, Chronic
  • Auckland, New Zealand
  • +1 more
Dec 19, 2022

Predict Liver Fibrosis in Chronic Hepatitis B Infection

Not yet recruiting
  • Fibrosis, Liver
  • Liver Fibroscan
  • Assiut, Egypt
    AssiutU
Oct 2, 2022

Hepatitis B, Chronic Trial in Toronto (Tenofovir disoproxil fumarate)

Active, not recruiting
  • Hepatitis B, Chronic
  • Tenofovir disoproxil fumarate
  • Toronto, Ontario, Canada
    University Health Network - Toronto General Hospital
Nov 1, 2022

Hepatitis b Virus Trial in New York (HepB mAb19, Sterile Saline)

Not yet recruiting
  • Hepatitis b Virus
  • HepB mAb19
  • Sterile Saline
  • New York, New York
  • +1 more
May 12, 2023

Hepatitis B Trial in Cambridge (GSK3965193, Placebo to match GSK3965193, Bepirovirsen)

Recruiting
  • Hepatitis B
  • Cambridge, United Kingdom
    GSK Investigational Site
Jun 14, 2022

HIV, Hepatitis C and Hepatitis B Infection Among Detainees in

Recruiting
  • HIV Infections
  • +2 more
  • Rapid diagnosis test against HIV and hepatitis C and B
  • Nîmes, France
    CHU Nîmes
Mar 17, 2022

Chronic Hepatitis b, Liver Fibrosis Trial in Konya (Serum regucalcin level)

Completed
  • Chronic Hepatitis b
  • Liver Fibrosis
  • Serum regucalcin level
  • Konya, Turkey
    Konya Training and Research Hospital
Jun 23, 2022

Chronic Hepatitis B Virus Infection Trial in Guangzhou (Entecavir, Entecavir combined with Tenofovir Amibufenamide)

Recruiting
  • Chronic Hepatitis B Virus Infection
  • Entecavir
  • Entecavir combined with Tenofovir Amibufenamide
  • Guangzhou, Guangdong, China
    The Third Affiliated Hospital of Sun Yat-sen University
May 15, 2022

COVID-19 Infection and Its Clinical Prognosis in Chronic

Recruiting
  • Chronic Hepatitis B
  • COVID-19 Infection
  • Beijing, Beijing, China
    Department of Hepatology Division 2, Beijing Ditan Hospital
Mar 28, 2023

Social-environmental, Psychosocial, Behavioral, Clinical and

Recruiting
  • Chronic Viral Hepatitis
  • Hepatitis B Infection
  • Interview
  • +2 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University Hospital
Nov 2, 2021

Chronic Hepatitis B and Hepatitis D Co-infection Trial in Changchun (HH-003 20mg/kg, HH-003 3mg/kg)

Active, not recruiting
  • Chronic Hepatitis B and Hepatitis D Co-infection
  • HH-003 20mg/kg
  • HH-003 3mg/kg
  • Changchun, Jilin, China
    First Hospital of Jilin University
Dec 30, 2022

Chronic Hepatitis B Trial in Taiwan, Thailand (ChAdOx1-HBV, MVA-HBV, Nivolumab)

Not yet recruiting
  • Chronic Hepatitis B
  • ChAdOx1-HBV
  • +2 more
  • Chiayi City, Taiwan
  • +9 more
Apr 22, 2022

Hepatitis B Infection Trial in Dhaka (Hepa-B, Engerix B)

Completed
  • Hepatitis B Infection
  • Hepa-B
  • Engerix B
  • Dhaka, Mirpur, Bangladesh
    Mirpur Field Office
Feb 10, 2022

Chronic Hepatitis b, Anti-PD-1 Antibody, Peg-IFNa Trial in Chongqing (Anti-PD-1 antibody, NAs, Peg-IFNa)

Not yet recruiting
  • Chronic Hepatitis b
  • +2 more
  • Anti-PD-1 antibody
  • +2 more
  • Chongqing, Chongqing, China
    The 2nd affiliated Hospital of Chongqing Medical University
Mar 14, 2023

Chronic Hepatitis B Trial (RO7565020, Placebo, Nucleos(t)ide analogue (NUC) treatment)

Not yet recruiting
  • Chronic Hepatitis B
  • (no location specified)
Feb 28, 2023

Chronic HBV Infection Trial in Shenzhen (Peginterferon alfa-2b combined and ETV)

Recruiting
  • Chronic HBV Infection
  • Peginterferon alfa-2b combined and ETV
  • Shenzhen, China
    Shenzhen Third People Hospital
Mar 19, 2023

Chronic Hepatitis b, Anti-PD-1 Antibody Trial in Chongqing (Anti-PD-1 antibody, NAs)

Not yet recruiting
  • Chronic Hepatitis b
  • Anti-PD-1 Antibody
  • Anti-PD-1 antibody
  • NAs
  • Chongqing, Chongqing, China
    The 2nd affiliated Hospital of Chongqing Medical University
Mar 3, 2023

Vaccination Reaction, Hepatitis B Virus Infection, Digestive System Disorders of Fetus and Newborn Trial in Chongqing

Recruiting
  • Vaccination Reaction
  • +4 more
    • Chongqing, Chongqing, China
      Children's Hospital of Chongqing Medical University
    Sep 7, 2023

    Hepatocellular Carcinoma Trial (Lenvatinib at a dose of 8 mg or 12 mg based on body weight + tislelizumab for one 21-day cycle)

    Not yet recruiting
    • Hepatocellular Carcinoma
    • Lenvatinib at a dose of 8 mg or 12 mg based on body weight + tislelizumab for one 21-day cycle
    • (no location specified)
    Jun 12, 2023

    Hepatic Steatosis and Chronic Hepatitis B Virus

    Not yet recruiting
    • Chronic Hepatitis
    • Liver biopsy
    • Sohag, Egypt
      Faculty of medicine
    Dec 28, 2022

    Burden of Hepatitis D Virus Infection in China Through

    Not yet recruiting
    • Hepatitis D
    • +3 more
    • HDV-Ab (IgG), HDV-RNA, RNA genotype
    • (no location specified)
    Nov 1, 2022

    Hepatitis C Virus Infection

    Active, not recruiting
    • Hepatitis C
    • Hepatitis B
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Dec 30, 2022

      Chronic Hepatitis B Infection Trial in Taichung (Tenofovir disoproxil fumarate, Historical Data)

      Completed
      • Chronic Hepatitis B Infection
      • Tenofovir disoproxil fumarate
      • Historical Data
      • Taichung, Taiwan
        Taichung Veterans General Hospital
      Apr 29, 2022

      Hepatitis B, Chronic, Hepatitis D Trial in Chisinau, Kyiv (ATI-2173, Viread, AB-729)

      Terminated
      • Hepatitis B, Chronic
      • Hepatitis D
      • Chisinau, Republic Of Moldova, Moldova, Republic of
      • +1 more
      Nov 15, 2022